Seroprevalence study of hepatitis A virus in Fars province, southern Iran

Hepatitis Monthly

Volumn 11, Issue 4, 2011, Pages 285-288

  Taghavi, Seyed Alireza ^a   Asl, Mohammad Kazem Hosseini ^a   Talebzadeh, Mozaffar ^a   Eshraghian, Ahad ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Epidemiology; Hepatitis A virus; Iran; Seroprevalence

Indexed keywords

HEPATITIS A ANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; FAMILY; FEMALE; HEPATITIS A; HUMAN; IRAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MARRIAGE; RURAL AREA; SEROPREVALENCE; URBAN AREA; WATER SUPPLY; WORK;

EID: 80052588842     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kof RS. Hepatitis A. Lancet. 1998;351(9116):1643-1649.
2. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect. 2004;132(6):1005-1022.
3. Shapiro CN, Margolis HS. Worldwide epidemiology of hepatitis A virus infection. J Hepatol. 1993;18(Suppl 2):S11-S14.
4. Melnick JL. History and epidemiology of hepatitis A virus. J Infect Dis. 1995;171(Suppl 1):S2-S8.
5. Sofan M, Aghakhani A, Farazi AA, Banifazl M, Etemadi G, Azad-Armaki S, et al. Seroepidemiology of hepatitis A virus in children of diferent age groups in Tehran, Iran: implications for health policy. Travel Med Infect Dis. 2010;8(3):176-179.
6. Nourollahi T, editor. An Introduction to Iran's 2006 Population and Housing Census. 24th Population Census conference; 2009; Hong Kong, China.
7. Abdolvahab M, Behnaz K, Sima B, M T. Hepatitis a in young adults in the golestan province, northeast of Iran. J Glob Infect Dis. 2010;2(2):198-199.
8. Elikaei A, Sharif Z, Shooshtari MM, Hosseini M, Marouf Y. Prevalence of HAV among healthy blood donors referring to Tehran transfusion center. Iran J Public Health. 2008;37(4):126-130.
9. Mehr AJ, Ardakani MJ, Hedayati M, Shahraz S, Mehr EJ, Zali MR. Age-specifc seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran. Eur J Epidemiol. 2004;19(3):275-278.
10. Merat S, Rezvan H, Nouraie M, Abolghasemi H, Jamali R, Amini-Kafabad S, et al. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med. 2010;13(2):99-104.
11. Roushan MR, Bijani A, Sagheb R, Jazayeri O. Prevalence of hepatitis A IgG in individuals with chronic hepatitis B infection in Babol. East Mediterr Health J. 2007;13(5):1108-1113.
12. Saha SK, Saha S, Shakur S, Hanif M, Habib MA, Datta SK, et al. Community-based cross-sectional seroprevalence study of hepatitis A in Bangladesh. World J Gastroenterol. 2009;15(39):4932-4937.
13. Das K, Jain A, Gupta S, Kapoor S, Gupta RK, Chakravorty A, et al. The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the European countries. Eur J Epidemiol. 2000;16(6):507-510.
14. Dhawan PS, Shah SS, Alvares JF, Kher A, Shankaran, Kandoth PW, et al. Seroprevalence of hepatitis A virus in Mumbai, and im-munogenicity and safety of hepatitis A vaccine. Indian J Gastro-enterol. 1998;17(1):16-28.
15. Murhekar MV, Sehgal SC, Murhekar KM, Padbhidri SP, Chitambar SD, Arankalle VA. Changing scenario of hepatitis A virus and hepatitis E virus exposure among the primitive tribes of Andaman and Nicobar Islands, India over the 10-year period 1989-99. J Viral Hepat. 2002;9(4):315-321.
16. Lee D, Cho YA, Park Y, Hwang JH, Kim JW, Kim NY, et al. Hepatitis a in Korea: epidemiological shift and call for vaccine strategy. Intervirology. 2008;51(2):70-74.
17. Kunasol P, Cooksley G, Chan VF, Isahak I, John J, Loleka S, et al. Hepatitis A virus: declining seroprevalence in children and adolescents in Southeast Asia. Southeast Asian J Trop Med Public Health. 1998;29(2):255-262.